Why the application of IVIG might be beneficial in patients with COVID-19 – Authors' reply - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue The Lancet Respiratory Medicine Année : 2022

Dates et versions

hal-03894519 , version 1 (12-12-2022)

Identifiants

Citer

Aurélien Mazeraud, Michel Wolff, Bruno Lucas, Tarek Sharshar. Why the application of IVIG might be beneficial in patients with COVID-19 – Authors' reply. The Lancet Respiratory Medicine, 2022, 10 (2), pp.e16. ⟨10.1016/S2213-2600(21)00550-6⟩. ⟨hal-03894519⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More